Strikingly, Shh signalling was predominantly activated in breast cancer cells in contact with stromal cells in response to chemotherapy, as well as Wnt, STAT3 and TGFβ pathways, which are involved in progenitor and stem cell renewal, metabolism [46], metastasis and chemoresistance [47]. The gene discussed is SHH; the disease is breast carcinoma.